Science Current Events | Science News | Brightsurf.com
 

Drug Discovery Current Events | Drug Discovery News | 2

Sort By: Page Views | Date

Leicester breakthrough in eye disease
Researchers at the University of Leicester have identified for the first time a gene which causes a distressing eye condition. Their discovery, as reported in the journal Nature Genetics, is expected to lead to better treatments for the condition.   view more (2006-12-13)

UCSB researchers discover shape matters to macrophages
Researchers at UC Santa Barbara have made a surprising discovery: phagocytosis depends more on particle shape than size.   view more (2006-03-22)

CENIX BIOSCIENCE, A PIONEER IN RNAi TECHNOLOGIES, RAISES EURO 5 MILLION IN INTERNATIONAL FINANCING ROUND
Dresden, Germany, 10th September, 2002 - Cenix BioScience GmbH, a pioneer in RNA mediated interference (RNAi)-based technologies and therapeutics, today announced that it has raised EUR 5 million (Euro) in a new international financing round to fund its next stage of development and progress its novel RNAi drug development programmes. The... view more... (2002-09-10)

Positive outcome of Medicare drug benefit
An editorial by Richard Platt, professor and chair of the Department of Ambulatory Care and Prevention, says that an unintended effect of the Medicare Drug Benefit could be the creation of the world's most valuable resource for understanding how drugs are used, as well as their risks and benefits, especially among the elderly and chronically ill   view more (2005-12-30)

Scientists find genetic pathway that could lead to drugs for kidney disease
Scientists at the University of California, Santa Barbara have reported a discovery at the cellular level that suggests possibilities for drug therapy for kidney disease.   view more (2006-02-01)

DNA that controls the malaria parasite's disguise mechanism
Professor Alan Cowman, Dr Brendan Crabb and their research teams at WEHI have identified how the most lethal malaria parasite, Plasmodium falciparum, is able to disguise itself from the human immune system.   view more (2006-01-04)

The Cambridge-MIT Institute launches an initiative to accelerate next-generation drug discovery
The Cambridge-MIT Institute (CMI) is today launching a new initiative to unite biologists and medical researchers with physicists, engineers, computer scientists and mathematicians to work on an innovative approach to discovering the next generation of drugs. CMI is funding a transatlantic Next-Generation Drug Discovery Community that will bring... view more... (2004-03-24)

Research into viral infections: Cardiff University enters agreement with Glaxo Wellcome Inc.
The collaboration is based on the work of the research group of Professor Chris McGuigan at Cardiff University's Welsh School of Pharmacy, which has discovered a new method for inserting charged molecules into living cells. The Cardiff team is collaborating with virologists at the Rega Institute1 in Belgium on this invention, which may have major... view more... (1999-07-20)

From genome to therapy: integrating new technologies with drug development
The sequencing of human and other genomes has accelerated dramatically in recent years due, in large part, to the continuous development of increasingly powerful sequencing technologies. Indeed, complete genomes have now been sequenced, a feat unthinkable only a decade ago. We are entering an era in which the emphasis must now be on strategies to... view more... (1999-05-27)

Solving the drug price crisis
The mounting U.S. drug price crisis can be contained and eventually reversed by separating drug discovery from drug marketing and by establishing a non-profit company to oversee funding for new medicines, according to two MIT experts on the pharmaceutical industry.   view more (2008-03-18)

New journal for the 21st century drug hunter launched
Drug discovery researchers will be able to keep up-to-date with the latest developments in therapeutic drug discovery with a new peer-reviewed journal, Current Opinion in Investigational Drugs, launched today (25 September) by PharmaPress Ltd. This monthly journal aims to provide a comprehensive review of developmental drugs and the... view more... (2000-09-20)

Oxford spin-out company may lead to treatments for a range of diseases
Oxford University's latest spin-out company, ReOx, is set to develop potential therapies for a huge range of diseases, from heart disease to stroke, using world-leading expertise in biology and chemistry. The company was spun out this summer and has raised £2 million in capital investment. ReOx is a drug discovery company whose technology... view more... (2003-07-17)

Drug addiction treatment sees drop in success rate
The proportion of drug users who completed treatment for drug addiction decreased between 1998 and 2002, although the overall number of drug users who entered treatment increased.   view more (2006-08-11)

McMaster researchers discover a new antibacterial lead
Antibiotic resistance has been a significant problem for hospitals and health-care facilities for more than a decade. But despite the need for new treatment options, there have been only two new classes of antibiotics developed in the last 40 years.   view more (2009-09-28)

Plants can be used to study how and why people respond differently to drugs
While prescription medications work successfully to cure an ailment in some people, in others the same dose of the same drug can cause an adverse reaction or no response at all.   view more (2007-09-27)

Not all 'drug-related deaths' are 'drug-related'
UK estimates of 'drug-related deaths' (DRDs) include mortalities of drug abusers and non-drug abusers. So these figures may not be the best way of monitoring the performance of Drug and Alcohol Action Teams.   view more (2007-08-09)

EU Funding Helps Fight Liver Cancer
The fight against liver cancer, one of the leading causes of cancer death worldwide, is being helped by 2.5 million euros from the EU's Framework Programme.   view more (2005-02-22)

University of Helsinki to coordinate two large EU research projects
The European Union has granted nearly 25 MEUR to two large-scale interdisciplinary research projects coordinated by the University of Helsinki. The project leaders are professor Raimo Tuominen from the UH's Faculty of Pharmacy and Academy professor Kari Alitalo from UH's Molecular and Cancer Biology Laboratory. Both projects are part of the... view more... (2004-08-24)

Heart smart: new drug improves blood flow
A new drug has been shown to improve blood flow in diseased arteries, reducing the risk of high blood pressure and heart attacks.   view more (2006-09-05)

Scientists develop novel method to generate functional hepatocytes for drug testing
Scientists have for the first time produced liver cells from adult skin cells using the induced pluripotent stem cell (iPSC) technology.   view more (2009-10-21)
Sort By: Page Views | Date
© 2009 BrightSurf.com